Elon Musk's Neuralink to Test Implant to Restore Vision in Humans
Neuralink has received FDA approval to test the Blindsight implant for vision restoration. The device has already been successfully tested on monkeys, and will now begin testing on humans. The implant will help restore vision to the visually impaired and even completely blind.
Elon Musk's Neuralink has received FDA approval to test the Blindsight implant to restore vision in humans. The device has already been successfully tested on monkeys, and according to Musk, no animals were harmed during the tests.
The Blindsight chip is designed to restore vision in both visually impaired and completely blind people. Rehabilitation will be gradual: at the initial stages, users will be able to see in low resolution, but over time the picture will become clearer and may even surpass the natural capabilities of vision.
This is an important step towards using neurotechnology to improve the quality of life of people with visual impairments.
The editorial board is not responsible for the content and accuracy of material taken, sent or obtained from other sources. The publication of such materials is for informational purposes only and does not imply automatic endorsement or approval of their content.
